Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fulvestrant in Recurrent/Metastatic Endometrial Carcinoma
NCT00006903Phase 2Unknown
- Sponsor
- GOG Foundation
- Start
- Aug 2004
- Primary completion
- Mar 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of fulvestrant in endometrial carcinoma, sponsored by GOG Foundation. Status: unknown.
02
Drugs
fulvestrant
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT00006903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006903.